Companies included in WDNA
This is WDNA's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–86 of 86.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| MRNA | Moderna Inc | 2,024 | NS | 4.541784% |
| JNJ | Johnson & Johnson | 292 | NS | 3.15288% |
| UTHR | United Therapeutics Corporation | 107 | NS | 2.802697% |
| PFE | Pfizer Inc. | 2,208 | NS | 2.738725% |
| LLY | Eli Lilly & Co. | 65 | NS | 2.640857% |
| STOK | Stoke Therapeutics Inc | 1,759 | NS | 2.529895% |
| NTRA | NATERA INC | 286 | NS | 2.526542% |
| AMGN | Amgen Inc. | 151 | NS | 2.346858% |
| TWST | Twist Bioscience Corporation | 1,103 | NS | 2.315284% |
| AZN | AstraZeneca PLC | 262 | NS | 2.282467% |
| GPCR | Structure Therapeutics Inc | 1,034 | NS | 2.201506% |
| FOLD | Amicus Therapeutics Inc. | 3,435 | NS | 2.194054% |
| BNTX | BioNTech SE | 533 | NS | 2.092587% |
| IONS | Ionis Pharmaceuticals, Inc. | 621 | NS | 2.059804% |
| GILD | Gilead Sciences Inc. | 318 | NS | 1.957712% |
| CRSP | CRISPR Therapeutics AG | 891 | NS | 1.872247% |
| IMNM | Immunome Inc | 1,928 | NS | 1.862551% |
| NSISB | Novonesis (Novozymes) B | 711 | NS | 1.852323% |
| BEAM | BEAM THERAPEUTICS INC | 1,726 | NS | 1.816842% |
| TXG | 10X Genomics Inc | 1,900 | NS | 1.781787% |
| DAR | Darling Ingredients, Inc | 622 | NS | 1.699348% |
| NOVN | Novartis AG | 248 | NS | 1.647683% |
| ROIV | Roivant Sciences Ltd | 1,307 | NS | 1.599218% |
| KRYS | Krystal Biotech Inc | 138 | NS | 1.574669% |
| AGIO | Agios Pharmaceuticals Inc | 1,048 | NS | 1.566086% |
| BG | Bunge Global SA | 274 | NS | 1.539536% |
| NOVOB | Novo Nordisk A/S | 945 | NS | 1.48618% |
| NTLA | Intellia Therapeutics Inc | 2,622 | NS | 1.484817% |
| CTVA | Corteva Inc | 392 | NS | 1.449492% |
| ARWR | Arrowhead Pharmaceuticals Inc | 517 | NS | 1.431892% |
| VRTX | Vertex Pharmaceuticals Incorporated | 69 | NS | 1.361011% |
| RGNX | Regenxbio Inc. | 3,572 | NS | 1.322232% |
| ACLX | Arcellx Inc | 252 | NS | 1.278116% |
| ALLO | Allogene Therapeutics Inc | 11,574 | NS | 1.247457% |
| BMY | Bristol-Myers Squibb Company | 447 | NS | 1.197542% |
| 4502 | Takeda Pharmaceutical Co Ltd. | 742 | NS | 1.166908% |
| REGN | Regeneron Pharmaceuticals, Inc. | 33 | NS | 1.126272% |
| GMAB | Genmab As | 931 | NS | 1.103374% |
| VBK | Verbio SE | 449 | NS | 1.046627% |
| BMRN | Biomarin Pharmaceutical Inc. | 410 | NS | 1.023076% |
| BAYN | Bayer AG | 506 | NS | 1.014288% |
| ARGX | Argenx SE | 29 | NS | 0.935453% |
| VKTX | Viking Therapeutics Inc. | 636 | NS | 0.91417% |
| VCYT | Veracyte Inc | 637 | NS | 0.906322% |
| EDIT | Editas Medicine Inc | 8,182 | NS | 0.892707% |
| DHR | Danaher Corporation | 106 | NS | 0.887762% |
| ARCT | Arcturus Therapeutics Holdings Inc | 2,494 | NS | 0.850484% |
| ABSI | ABSCI CORP | 6,319 | NS | 0.837379% |
| IOVA | Iovance Biotherapeutics Inc | 5,273 | NS | 0.817555% |
| TEM | Tempus AI Inc. | 390 | NS | 0.779018% |
| MRK | Merck & Co., Inc | 146 | NS | 0.775773% |
| QURE | Uniqure N.V. | 1,049 | NS | 0.75761% |
| RGEN | Repligen Corporation | 145 | NS | 0.754639% |
| BIIB | Biogen Inc | 91 | NS | 0.736932% |
| EXEL | Exelixis, Inc. | 377 | NS | 0.714249% |
| ZTS | Zoetis Inc. | 131 | NS | 0.684034% |
| RVMD | Revolution Medicines Inc | 153 | NS | 0.657254% |
| SANA | Sana Biotechnology Inc | 5,002 | NS | 0.636339% |
| HALO | Halozyme Therapeutics Inc | 222 | NS | 0.633781% |
| GPRE | Green Plains Inc. | 849 | NS | 0.616916% |
| DNA | Ginkgo Bioworks Holdings Inc | 2,191 | NS | 0.593274% |
| ZEAL | Zealand Pharma As | 284 | NS | 0.570632% |
| BBIO | Bridgebio Pharma Inc | 172 | NS | 0.564203% |
| SYNSY | Syensqo SA | 216 | NS | 0.543956% |
| GERN | Geron Corp. | 8,007 | NS | 0.526997% |
| RARE | Ultragenyx Pharmaceuticals Inc | 560 | NS | 0.518232% |
| GNS | Genus PLC | 323 | NS | 0.445912% |
| ILMN | Illumina Inc | 80 | NS | 0.435576% |
| TECH | Bio-Techne Corp | 185 | NS | 0.427064% |
| SRPT | Sarepta Therapeutics Inc | 427 | NS | 0.41043% |
| SDGR | Schrodinger Inc. | 748 | NS | 0.375346% |
| TSN | Tyson Foods, Inc. | 132 | NS | 0.373578% |
| CRBU | Caribou Biosciences Inc | 4,413 | NS | 0.370373% |
| ALNY | Alnylam Pharmaceuticals Inc. | 25 | NS | 0.365384% |
| ONT | Oxford Nanopore Technologies Plc | 5,557 | NS | 0.358656% |
| RXRX | Recursion Pharmaceuticals Inc | 2,394 | NS | 0.32465% |
| RCKT | Rocket Pharmaceuticals Inc | 2,033 | NS | 0.321494% |
| DSVXX | DREY INST PREF GOV MM-M | 7,181.94 | NS | 0.317244% |
| NUF | Nufarm Ltd. | 4,529 | NS | 0.279519% |
| TMO | Thermo Fisher Scientific Inc | 12 | NS | 0.260545% |
| PACB | Pacific Biosciences Of California Inc. | 4,371 | NS | 0.254863% |
| QGEN | QIAGEN NV | 135 | NS | 0.23877% |
| FATE | Fate Therapeutics Inc. | 4,192 | NS | 0.222206% |
| FMC | FMC Corp. | 267 | NS | 0.203094% |
| BHVN | Biohaven Ltd | 389 | NS | 0.145369% |
| DTRXX | DREYFUS TRSY OBLIG CASH M | 1,113.83 | NS | 0.049201% |
SEC N-PORT snapshot as of .